OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection.
暂无分享,去创建一个
J. Barry | S. Alexander | D. Norman | G. Goldstein | K. Henell | M. Leone | M. Funnell
[1] D. Droz,et al. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. , 1986, Transplantation.
[2] R. Colvin,et al. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. , 1986, Transplantation.
[3] J. Barry,et al. Monoclonal antibody for reversal of acute renal allograft rejection in pediatric patients. , 1985, Transplantation.
[4] R. Colvin,et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. , 1981, The New England journal of medicine.
[5] E. Reinherz,et al. Monoclonal antibodies defining distinctive human T cell surface antigens. , 1979, Science.
[6] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[7] J. Barry,et al. Reversal of acute allograft rejection with monoclonal antibody , 1985 .
[8] S. Orkin,et al. Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex , 1984, Nature.